EMERGENT BIOSOLUTIONS
12.10
07-November-24 11:30:05
15 minutes delayed
Stocks
+2.90
+31.51%
Today's range
10.98 - 12.73
ISIN
N/A
Source
NYSE
-
06 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic Focus
09 Jan 2023 06:59:00 By Nasdaq GlobeNewswire
-
05 Jan 2023 17:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
14 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results For Third Quarter 2022
08 Nov 2022 16:16:51 By Nasdaq GlobeNewswire
-
01 Nov 2022 16:05:14 By Nasdaq GlobeNewswire
-
18 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
26 Sep 2022 16:12:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
06 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
10 Aug 2022 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for Second Quarter 2022
01 Aug 2022 16:05:47 By Nasdaq GlobeNewswire
-
18 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
07 Jul 2022 16:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors
06 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
24 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
21 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
02 Jun 2022 08:20:49 By Nasdaq GlobeNewswire
-
16 May 2022 06:32:17 By Nasdaq GlobeNewswire
-
12 May 2022 06:30:00 By Nasdaq GlobeNewswire